Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Arvostustunnusluvut
P/E
—
Ennustettu P/E
8.38x
Tulos per osake (EPS)
-3.68
PEG
—
P/B
1.50x
Beta-kerroin
0.89
Kannattavuus
Liikevaihdon kasvu
-2.50%
Tuloskasvu
—
Bruttomarginaali
59.35%
Liikevoittomarginaali
29.02%
Nettomarginaali
-7.94%
Oman pääoman tuotto (ROE)
-12.37%
Sijoitetun pääoman tuotto (ROA)
2.97%
Taloudellinen asema
Velkaantumisaste (D/E)
1.44x
Current ratio
1.01x
Quick ratio
0.61x
Vapaa kassavirta
8.5B
Osingot
Osinkotuotto
0.28%
Osingonjakosuhde
163.27%
Osingon irtoamispäivä
2026-04-27
Lähde: Yahoo Finance
Kurssitavoite
Alin
23,00 €
Keskiarvo
46,53 €
Korkein
60,00 €
Lähde: Yahoo Finance
Ei viimeaikaisia tiedotteita